AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$PG

Gama Paul sold $323K of PG

Gama Paul (CEO- Health Care) sold 2,225 shares of PROCTER & GAMBLE Co (PG) at $145.34 ($0.32M total) on 2026-10-05.

Original reporting
SEC EDGAR · Gama Paul
Published Oct 6, 2026, 8:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 8:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$PG
Bearish
medium confidence
Mentioned
$PG
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PGBearishLow
01

Why it matters

The disclosed sale is modest and unlikely to move the stock significantly, but may be noted by short-term traders.

02

Market read

A routine insider sale with limited material impact; low trading relevance.

03

What to watch

No change in company fundamentals; the sale represents a small fraction of total shares.

Relevance 4/10Novelty 4/10Timing: after-hours disclosure

Background

Form 4 filings disclose insider transactions; traders monitor them for potential signals.

Company-level read

Ticker impact

$PGBearishMedium confidence
Context

CEO Gama Paul sold 2,225 shares of Procter & Gamble for $323,381, reducing his stake to 51,124 shares.

Expected impact

likely modest pressure as the market prices in the insider sell

Evidence & confidence

The sale size is modest relative to market cap, but insider activity is watched by traders.

Market effects

Sector

Minimal impact on consumer staples sector; similar insider sales are common.

Regional

U.S. market only; no broader regional effect.

Global

Low relevance globally.

Counterpoint

What could challenge this read

The sale could be a routine liquidity move, not a negative signal.

Key entities

  • Individual
    Gama Paul

    CEO of Health Care division at Procter & Gamble

  • Company
    Procter & Gamble Co

    Consumer goods conglomerate (ticker PG)

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

PG insider trading history →

Related articles

$PGMedAI 9/10

The Procter & Gamble Company closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030…

PROCTER & GAMBLE Co (PG) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On November 3, 2026, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030, €1,000,000,000 aggregate principal amount of 4.100% Notes due November

SEC EDGAR 8-K
$PGMedAI 9/10

The Procter & Gamble Company closed an underwritten public offering of $750,000,000 aggregate principal amount of 5.125% Notes due October 30, 2031…

PROCTER & GAMBLE Co (PG) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On October 30, 2026, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 5.125% Notes due October 30, 2031, $750,000,000 aggregate principal amount of 5.300% Notes due October 30

SEC EDGAR 8-K